To evaluate MDM2 and MDMX expression with EMT in clinical cancer samples, we analyzed archived formalin-fixed paraffin-embedded tissue specimens from a cohort of prostate cancer (CaP) and breast cancer (BrCa) patients who underwent surgical resection of the primary tumor and its lymph node (LN) metastases. The gene discussed is MDM2; the disease is invasive breast carcinoma.